<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract Next generation sequencing techniques are powerful high throughput methods that have enabled the comprehensive documentation of genetic lesions in numerous <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In recent times, the genome of multiple different B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> including <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C0024419" disease_type="Neoplastic Process" abbrv="">Waldenström macroglobulinemia</z:e> have been documented </plain></SENT>
<SENT sid="2" pm="."><plain>Between them, these studies have reinforced and provided insight into the mechanisms for the dysregulation of known pathways (e.g. NF-κB), uncovered the importance of new pathways for <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> (e.g. <z:chebi fb="2" ids="33699">mRNA</z:chebi> processing), identified disease-defining mutations, and provided meaningful new targets which are already being translated into therapeutic interventions </plain></SENT>
<SENT sid="3" pm="."><plain>This review summarises the molecular lesions that have been discovered in B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> thus far by studies utilising high-throughput sequencing techniques and the aberrations in the numerous intracellular pathways that have been shown to be involved </plain></SENT>
</text></document>